Polaris Venture Partners Special Founders' Fund V, L.P.
10% Owner

Polaris Venture Partners Special Founders' Fund V, L.P. insider trades: Lyra Therapeutics (LYRA) stock buys and sales

10% Owner, Lyra Therapeutics Last trade May 5, 2020 39 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
43
Open-market trades
since 2013
14
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Polaris Venture Partners Special Founders' Fund V, L.P. reports to the SEC

and 8 more companies

Open-market buys and sales

43 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 5, 2020LYRA↑ Buy$1.0M
May 5, 2020LYRA↓ Sell$155K
Dec 17, 2019PHR↓ Sell$8.4M
Dec 17, 2019PHR↓ Sell$164K
Dec 17, 2019PHR↓ Sell$84K
Dec 17, 2019PHR↓ Sell$58K
Jul 22, 2019PHR↓ Sell$6.9M
Jul 22, 2019PHR↓ Sell$134K
Jul 22, 2019PHR↓ Sell$69K
Jul 22, 2019PHR↓ Sell$47K
Jul 17, 2019CDLX↓ Sell$1.9M
Jun 7, 2019CDLX↓ Sell$2.6M
Jun 6, 2019CDLX↓ Sell$1.8M
May 28, 2019CDLX↓ Sell$2.3M
Sep 13, 2018CDLX↓ Sell$3.8M
Nov 20, 2017ASNS↑ Buy$5.0M
Jun 27, 2016SELB↑ Buy$2.1M
Aug 5, 2015TTOO↓ Sell$161K
Jul 24, 2015TTOO↓ Sell$232K
Jul 22, 2015TTOO↓ Sell$700K
Jul 17, 2015TTOO↓ Sell$732K
Jul 14, 2015TTOO↓ Sell$497K
Jul 10, 2015TTOO↓ Sell$731K
Jul 7, 2015TTOO↓ Sell$716K
Jul 1, 2015TTOO↓ Sell$724K
Jun 26, 2015TTOO↓ Sell$768K
Jun 23, 2015TTOO↓ Sell$545K
Jun 19, 2015GNCA↓ Sell$391K
Jun 17, 2015GNCA↓ Sell$747K
Jun 15, 2015PULM↑ Buy$734K
Feb 2, 2015OCUL↓ Sell$14.8M
Aug 14, 2014TRVN↓ Sell$222K
Aug 14, 2014GNCA↓ Sell$126K
Aug 13, 2014TRVN↓ Sell$35K
Aug 12, 2014GNCA↓ Sell$847K
Apr 15, 2014CERU↑ Buy$10.3M
Feb 10, 2014GNCA↑ Buy$2.8M
Feb 5, 2014TRVN↑ Buy$3.3M
Oct 4, 2013FATE↑ Buy$4.8M
Oct 4, 2013FATE↑ Buy$94K
Oct 4, 2013FATE↑ Buy$48K
Oct 4, 2013FATE↑ Buy$33K
Sep 25, 2013BIND↑ Buy$390K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other LYRA insiders

Open-market trades in the last 12 months

About Polaris Venture Partners Special Founders' Fund V, L.P.'s insider trades

Polaris Venture Partners Special Founders' Fund V, L.P. is a 10% owner of Lyra Therapeutics (LYRA). Since Sep 25, 2013, it has reported 12 open-market purchases worth $30.6M and 31 sales worth $51.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include conversions (13 filings), option exercises (4 filings), other transactions (4 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LYRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.